Thomas Fox
15Patents
5h-index
27Co-inventors
58Inventor score
Filing activity: Apr 18, 2007 → Dec 19, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8114878B2 | 6,7-dihydrothieno[3,2-d]pyrimidine for the treatment of inflammatory diseases | Chemistry; Metallurgy | 18 | Active |
| US8648085B2 | 1, 5-dihydro-pyrazolo (3, 4-D) pyrimidin-4-one derivatives and their use as PDE9A mudulators for the treatment of CNS disorders | Human Necessities | 7 | Active |
| US8486948B2 | Piperazinodihydrothienopyrimidine derivatives | Chemistry; Metallurgy | 6 | Active |
| US8637519B2 | Heterocycle-substituted piperazino-dihydrothienopyrimidines | Human Necessities | 5 | Active |
| US8754073B2 | Substituted piperazino-dihydrothienopyrimidines | Chemistry; Metallurgy | 5 | Active |
| US8623879B2 | 1-heterocyclyl-1,5-dihydro-pyrazolo[3,4-D] pyrimidin-4-one derivates and their use as PDE9A modulators | Human Necessities | 4 | Active |
| US9096603B2 | 1-heterocyclyl-1,5-dihydro-pyrazolo[3,4-D] pyrimidin-4-one derivatives and their use as PDE9A modulators | Human Necessities | 3 | Active |
| US8623901B2 | Compounds for the treatment of CNS disorders | Human Necessities | 3 | Active |
| US9102679B2 | Compounds for the treatment of CNS disorders | Human Necessities | 3 | Active |
| US9079905B2 | Compounds for the treatment of CNS disorders | Human Necessities | 2 | Active |
| US8772323B2 | Benzoxazole- and tetrahydrobenzoxazole-substituted pyridazinones as GPR119 agonists | Chemistry; Metallurgy | 0 | Active |
| US9115142B2 | Heterocycle-substituted piperazino-dihydrothienopyrimidines | Human Necessities | 0 | Active |
| US9090626B2 | Piperazino-dihydrothienopyrimidine derivatives | Chemistry; Metallurgy | 0 | Active |
| US8604039B2 | Dihydrothienopyrimidines for the treatment of inflammatory diseases | Chemistry; Metallurgy | 0 | Active |
| US8822474B2 | 6,7-dihydrothieno[3,2-d]pyrimidine for the treatment of inflammatory diseases | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.